Watchlist Price Alert

Artiva Biotherapeutics In... (ARTV)

NASDAQ: ARTV · Real-Time Price · USD

1.59

0.06 (3.92%)

At close: Jul 02, 2025, 3:59 PM

1.59

-0.31%

After-hours: Jul 02, 2025, 04:10 PM EDT

Artiva Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-65.37M	-28.72M	-58.79M	-71.83M	-17.99M
Depreciation & Amortization	2.43M	2.27M	1.16M	248K	73K
Stock-Based Compensation	6.98M	7.05M	6.58M	4.31M	297K
Other Working Capital	-2.46M	-27.36M	-2.38M	28.92M	249K
Other Non-Cash Items	1.25M	251K	n/a	18.55M	-278K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-325K	-28.28M	-3.87M	33.41M	4.36M
Operating Cash Flow	-55.03M	-47.43M	-50.83M	-15.3M	-13.54M
Capital Expenditures	-642K	-3.26M	-6.3M	-1.72M	-284K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-176.17M	-49.52M	n/a	n/a	n/a
Sales Maturities Of Investments	56.35M	26.8M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-120.46M	-25.98M	-6.3M	-1.72M	-284K
Debt Repayment	-149K	n/a	n/a	n/a	3M
Common Stock Repurchased	-4.18M	-12K	-5K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	51K	24.4M	-1.26M	-1.86M	-459K
Financial Cash Flow	162.23M	24.39M	-1.26M	152.75M	37.4M
Net Cash Flow	-13.27M	-49.01M	-58.39M	135.73M	23.57M
Free Cash Flow	-55.67M	-50.69M	-57.13M	-17.03M	-13.82M